Personalized medicine is the use of detailed information about a patient's genotype or level of gene expression and a patient's clinical data in order to select a medication, therapy or preventative measure that is suited to that patient. The benefits of this approach are in its accuracy, efficacy, safety and speed. Research findings over the past decade in biomedical research have unfolded a series of new, predictive sciences in the fields of genomics, proteomics, metabolomics, theranostics, and cytomics. These are a new approach to drug development, as well as increasing the potential of significantly more effective diagnosis, therapeutics, and patient care.
All reports in Personalized Medicine
|
White Paper: Tests That Personalize Show Faster Revenue Growth
4/6/2012 | published by: Kalorama Information
... growth than the IVD industry standard. The White Paper defines Personalized Medicine Diagnostics and provides examples of growth rates of personalized tests. This brief White Paper is based on information in Kalorama Information's full market ...
|
more...
|
|
|
Personalized Medicine Partnering Terms and Agreements, 3rd Edition
4/1/2012 | published by: CHI Insight Pharma Reports
... Companion diagnostics Pharmacogenomics Biomarkers Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Description The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access ...
|
more...
|
$4,995.00
|
|
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth
3/27/2012 | published by: GlobalData
... provides information and analysis on the global companion diagnostics market. The report provides information such as current trends and developments in the global companion diagnostics market (including recent deals and industry trends). The report also ...
|
more...
|
$500.00
|
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
... the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara ...
|
more...
|
$3,795.00
|
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy
2/1/2012 | published by: TriMark Publications
... of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than ...
|
more...
|
$3,400.00
|
|
Personalized Medicine Market Analysis
1/1/2012 | published by: RNCOS
... personalized medicines are in their nascent stages, it is expected to transform the biopharmaceutical and molecular diagnostics markets in the coming years. According to our new research report, “Personalized Medicine Market Analysis”, the US market ...
|
more...
|
$1,200.00
|
|
Personalized Medicine for Cancer
9/30/2011 | published by: GlobalData
... The report also provides insights on the companion diagnostics and marketed personalized drugs for cancer. Scope The report provides information on the concept of personalized medicines, Challenges in development of personalized medicine and Benefits of ...
|
more...
|
$500.00
|
|
Exploiting Information Technology Tools to Advance Personalized Medicine
5/1/2011 | published by: Decision Resources
... information; the need for patients, physicians, and biopharmaceutical companies to be connected; and the overall desire by governments to explore newer and cost-effective ways to deliver healthcare, IT is indeed a driving force that will ...
|
more...
|
$4,600.00
|
|
Personalized Medicine Partnering Terms & Agreements
4/1/2011 | published by: Current Partnering
... understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ...
|
more...
|
$4,995.00
|
|
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
1/1/2011 | published by: JZMed, Inc.
... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ...
|
more...
|
$3,285.00
|
|
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
12/1/2010 | published by: GBI Research
... and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics ...
|
more...
|
$3,500.00
|
|
Personalized Medicine - Opening Doors and Overcoming Challenges
11/1/2010 | published by: CBR Pharma Insights, LLC
... has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not ...
|
more...
|
$3,900.00
|
|
Personalized Medicine & Orphan Drugs Review and Outlook 2010
8/1/2010 | published by: PharmaLive Special Reports
... "medicine." Advancements in science and diagnostic technology are required to reach this standard of care. In addition, health agencies need to establish clear regulatory frameworks for this complicated field, insurers must allow for adequate reimbursement, ...
|
more...
|
$455.00
|
|
The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine
6/23/2010 | published by: Business Insights
... Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately ...
|
more...
|
$3,835.00
|
|
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
5/1/2010 | published by: Arrowhead Publishers
... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ...
|
more...
|
$2,495.00
|
|
Combination Drug/Diagnostic Products and Other Applications of Personalized Medicine-Strategic Issues Facing Companies in this Market
4/1/2010 | published by: CHI Insight Pharma Reports
... Personalized medicine has emerged as an important field for companies in both the pharmaceutical and the diagnostic industries. While many drugs in development and on the market today still follow the traditional approach where drugs ...
|
more...
|
$2,995.00
|
|
Combination Drug Diagnostics: Fueling Growth of Personalized Medicine Report
4/1/2010 | published by: CHI Insight Pharma Reports
... combinations Emerging new applications Strategic options for pharmaceutical and diagnostic companies Regulatory and reimbursement issues Physician education and acceptable hurdles Interviews with experts Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine examines the role of Rx/Dx ...
|
more...
|
$3,750.00
|
|
Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
2/14/2010 | published by: Renub Research
... from past trends to future scenario (2006 to 2015). Personalized medicine segments like Genetically Modified (GM) Products, Wellness & Disease Management, Targeted Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data ...
|
more...
|
$1,100.00
|
|
SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine
2/1/2010 | published by: Kalorama Information
... exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and ...
|
more...
|
$1,995.00
|
|
Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine
12/17/2009 | published by: Datamonitor
... be able to predict response to expensive biologic therapies and match specific treatments to patients based upon biomarker profiles. Scope Classification and overview of biomarkers used in routine clinical practice across five rheumatology indications. Identification ...
|
more...
|
$3,800.00
|
|
Business Strategy: Personalized Medicine Looking Forward
12/13/2009 | published by: IDC
... key signposts of progress, market drivers impacting the segment, and both near- and long-term market opportunities for the segment. As we continue to hear more and more about broad efforts to transform the health industry ...
|
more...
|
$4,500.00
|
|
Regulatory and Legislative Activities: Shaping Biomarker and Diagnostic Use and Driving Personalized Medicine
11/13/2009 | published by: Decision Resources
... to the industry by publishing guidance and requesting commentary. Additionally, recent legislation, such as GINA, is giving companies new opportunities to further their efforts in personalized medicine. However, plenty of barriers still exist: some are ...
|
more...
|
$4,600.00
|
|
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
10/21/2009 | published by: Datamonitor
... Currently, there are 77 agents in development for CRC, 4 of which are in late-phase development. Collectively, they are forecast to achieve sales of $1,398m by 2018. Scope Examination of the CRC pipeline with in-depth ...
|
more...
|
$11,400.00
|
|
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach
8/1/2009 | published by: Business Insights
... of nutrition means that better nutritional care of patients is increasingly on the agenda of governments and healthcare professionals alike. Add to that the rise in diseases (often associated with aging populations) that can be ...
|
more...
|
$3,835.00
|
|
Personalized Medicine: Technologies and the Global Market
7/1/2009 | published by: BCC Research
... for the worldwide market for personalized medicine Estimates the growth of all submarkets for personalized medicine in terms of technology, products, services, geography and applications areas Analyzes the current personalized medicine business model and looks ...
|
more...
|
$4,850.00
|
